Hiroshi Suetsugu
Shimane University
17 Papers
178 Citations
Hiroshi Suetsugu is an academic researcher from Shimane University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 11, co-authored 16 publications.
Chat about Author
Papers
Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
H. Sato,Shunji Ishihara,Kousaku Kawashima,N Moriyama,Hiroshi Suetsugu,Hideaki Kazumori,Toshihiko Okuyama,Mohammad Ak Rumi,R Fukuda,N Nagasue,Yoshikazu Kinoshita +10 more
TL;DR: The results suggest that induction of apoptosis together with G1 cell cycle arrest may be one of the mechanisms of the antiproliferative effect of PPARγ activation in human gastric cancer cells.
Neutrophil chemoattractant 2β regulates expression of the Reg gene in injured gastric mucosa in rats
Hideaki Kazumori,Shunji Ishihara,Eiichi Hoshino,Kousaku Kawashima,Nobuyuki Moriyama,Hiroshi Suetsugu,H. Sato,Kyoichi Adachi,Ryo Fukuda,Makoto Watanabe,Shin Takasawa,Hiroshi Okamoto,Hirokazu Fukui,Tsutomu Chiba,Yoshikazu Kinoshita +14 more
TL;DR: CINC-2 beta, expressed in damaged gastric mucosa, stimulates the production of Reg protein in ECL cells via CXCR-2 and may be involved in the accelerated healing of injured gastric Mudosa.
61
Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study.
Hirofumi Fujishiro,Kyoichi Adachi,Tomonori Imaoka,Tomoyuki Hashimoto,Naruaki Kohge,Nobuyuki Moriyama,Hiroshi Suetsugu,Kousaku Kawashima,Yoshinori Komazawa,Norihisa Ishimura,Shunji Ishihara,Yuji Amano,Yoshikazu Kinoshita +12 more
TL;DR: The aim of the present study was to investigate the preventive effect of the novel protease inhibitor ulinastatin on post‐ERCP pancreatitis.
52
Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole.
Kyoichi Adachi,Tomoyuki Hashimoto,Naoharu Hamamoto,Kazuya Hirakawa,Masatoshi Niigaki,Tatsuya Miyake,Hiroyuki Taniura,Masahiro Ono,Takekazu Kaji,Hiroshi Suetsugu,Junko Yagi,Yoshinori Komazawa,Takafumi Mihara,Tomoko Katsube,Hirofumi Fujishiro,Toshihiro Shizuku,S. Hattori,Shun Yamamoto,Yoshikazu Kinoshita +18 more
TL;DR: Whether there is any difference in the speed of symptom relief in patients with reflux esophagitis following the administration of these three proton pump inhibitors (PPI) is clarified.
47
Activation of prostaglandin E2-receptor EP2 and EP4 pathways induces growth inhibition in human gastric carcinoma cell lines.
Toshihiko Okuyama,Shunji Ishihara,Hiroshi Sato,M. A. K. Rumi,Kousaku Kawashima,Youichi Miyaoka,Hiroshi Suetsugu,Hideaki Kazumori,C.F.Ortega Cava,Yasunori Kadowaki,Ryo Fukuda,Yoshikazu Kinoshita +11 more
TL;DR: Gastric cancer cells have EP2 and EP4 receptors, and their selective activation is linked with the decreased cell proliferation, and the specific agonists of these receptors induced growth inhibition with an accompanying increase in cAMP production.
46